Symposiums

The limitations of currently available therapies for immune thrombocytopenia (ITP) mean that long-term responses are difficult to maintain…

This article reviews real-world data presented at the ADA Scientific Sessions 2024. It demonstrates the glycaemic range when Control-IQ Technology users do not manually bolus for extended periods

Myasthenia gravis (MG) is an autoimmune disease caused by autoantibodies targeting proteins on the neuromuscular junction. Around 85%…

During this symposium, held at the 10th Congress of the European Academy of Neurology (EAN), speakers highlighted that chronic insomnia…

Nipocalimab, a high-affinity, fully human, aglycosylated, effectorless, monoclonal antibody, has been developed as an add-on treatment…

Haemophilia A is an inherited deficiency in coagulation FVIII. Based on their residual FVIII activity levels, PwHA are considered to have…

For patients with the chronic progressive liver disease primary biliary cholangitis (PBC), personalised treatment is key to both…

This symposium, held on the first day of the 2024 European Academy of Allergy and Clinical Immunology (EAACI) Congress, aimed to broaden…

Hereditary angioedema (HAE) is a rare genetic condition characterised by unpredictable episodes of cutaneous or submucosal swelling in…

CMA is among the most frequently occurring food allergies in infancy, but pinpointing its precise prevalence in different age groups…

IgAN is an immune-complex mediated glomerular disease with an incidence rate of 0.03−10.5/100,000 persons/year…

The sponsor of the below article (GSK) have requested its retraction in accordance with their internal compliance requirements following…

The rare diseases Duchenne and Becker are X-linked recessive neuromuscular disorders.1 They are characterised by progressive…

Vilaseca opened the meeting by reminding the audience that the management and treatment of advanced PCa has…

A masterclass initiated, organised, and funded by UCB, sought to advance understanding and expertise of myelin oligodendrocyte…

Non-seizure symptoms in Dravet and Lennox-Gastaut syndromes can affect speech, gait, appetite, mood, development, and sleep and impact…

In patients with immunoglobulin A nephropathy, use of the endothelin 1 Type A/Ang II subtype 1 receptor antagonist sparsentan can decrease proteinuria and preserve kidney function

PBC is a chronic, progressive, immune-mediated cholestatic liver disease that involves gradual intrahepatic bile duct destruction…

Venter explained that CMA is by far the most common and complex presentation of food allergy, particularly in early childhood, with the…

For USA healthcare professionals only. This article highlights the increased infection risks associated with immunocompromised rheumatological patients presented at ACR 2023.

IgAN, which can lead to CKD and kidney failure, is the most common form of primary glomerulonephritis, predominantly…

Many patients experience impairment following a stroke, including motor or cognitive impairment, urinary incontinence, dysphagia…

First described by German physician Peter Emil Becker in the 1950s, Becker is an X-linked genetic recessive disorder. Like Duchenne…

The non-small cell lung cancer (NSCLC) treatment landscape has rapidly evolved over the last two decades. The addition of immuno-oncology…

The latest recommendations and upcoming treatment strategies for patients with oestrogen-receptor positive (ER+), human epidermal growth…

The sponsor of the below article (GSK) have requested its retraction in accordance with their internal compliance requirements following…

Psoriasis symptoms can be not only uncomfortable, irritating, and painful, but can also impact several aspects of a patients’ daily life…

Due to the clinical heterogenicity of HS, assessment of disease severity is complex, and over 20 different outcome measures have…

Vitiligo is an autoimmune skin disorder that causes depigmentation of the skin and/or leukotrichia of the hair, resulting from the…

This ERS International Congress 2023 review considers prioritising patient outcomes to ensure access to essential inhaled medicines when considering the carbon footprint of inhalers.

The main objective was to discuss unmet needs in the diagnosis and management of rare lung diseases, with a particular emphasis on alpha…

Approximately 262 million people have asthma globally, with around 1,000 asthma-related deaths every day. In Europe alone…

Rabe began the presentation by highlighting two hypothetical patients with different ages, physiologies, and backgrounds to contextualise…

Nebuliser therapy is a relevant therapy option for respiratory diseases, yet studies have demonstrated a wide variation in nebuliser drug…

During this symposium, global experts in dermatology gave a series of lectures focused on skin treatments and their benefits for patients…

This continuing medical education-accredited symposium, held at the 2023 International Society for Thrombosis and Haemostasis (ISTH)…

Obesity has become a serious public health issue worldwide, with its prevalence steadily increasing. The potential consequences of this…

This article was funded by Sanofi and is intended for healthcare professionals.